18 patients treated without harm, some benefit seen in slowing disease
(Newser) -
A breast cancer vaccine is one step closer to FDA approval after a study found it produced no harmful effects in 18 women treated, and showed some signs of slowing tumors, Reuters reports. Neuvenge is meant to treat people who already have cancer by triggering the immune system to fight...
More »
